Correlación de mamoglobina con otros biomarcadores de cáncer de seno en una población colombiana

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  2009-05-26

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Utilidad clínica de los marcadores tumorales

  2010influential reference
• Mammaglobin : A novel tumor marker for breast cancer

  2007cited by this paper
• Biology of Circulating mRNA

  2006cited by this paper
• Introducción a los marcadores tumorales séricos

  2006cited by this paper
• Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer

  2005cited by this paper
• Detección temprana del cáncer de mama: aspectos críticos para un programa de tamizaje organizado en Colombia Early detection of breast cancer: critical aspects for an organized screening programme in Colombia

  2005cited by this paper
• Evaluation of the quantitative analytical methods real-time PCR for HER-2 gene quantification and ELISA of serum HER-2 protein and comparison with fluorescence in situ hybridization and immunohistochemistry for determining HER-2 status in breast cancer patients.

  2005cited by this paper
• Mammaglobin a in breast cancer: Existence of multiple molecular forms

  2005influential reference
• Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.

  2004cited by this paper
• Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

  2004cited by this paper
• INCIDENCIA DE CÁNCER EN COLOMBIA: IMPORTANCIA DE LAS FUENTES DE INFORMACIÓN EN LA OBTENCIÓN DE CIFRAS ESTIMATIVAS

  2004influential reference
• Tumor Markers

  2003cited by this paper
• Lack of correlation between expression of human mammaglobin mRNA in peripheral blood and known prognostic factors for breast cancer patients

  2003influential reference
• Early detection: The power and the promise of DNA methylation markers

  2003cited by this paper
• Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.

  2002influential reference
• Tumor Markers: Physiology, Pathobiology, Technology, and Clinical Applications

  2002influential reference
• Marcadores tumorales de secreción: situación actual

  2002cited by this paper
• Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes.

  2002influential reference
• Mammaglobin a: a promising marker for breast cancer.

  2002cited by this paper
• Globocan 2000 : cancer incidence, mortality and prevalence worldwide

  2001influential reference
• Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.

  2001cited by this paper
• Detection of mammaglobin expressing cells in blood of breast cancer patients.

  2000cited by this paper
• Android obesity at diagnosis and breast carcinoma survival

  2000cited by this paper
• Hormone Replacement Therapy and Breast Cancer Risk

  2000cited by this paper
• Mammaglobin expression in primary, metastatic, and occult breast cancer.

  1999cited by this paper
• [Reproductive risk factors associated with breast cancer in Colombian women].

  1999cited by this paper
• Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer.

  1996cited by this paper
• Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.

  1996cited by this paper
• The natural history of ductal carcinoma in situ. Implications for clinical decision making

  1995cited by this paper
• In situ breast carcinoma.

  1993cited by this paper
• Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

  1990cited by this paper
• Breast disease: tissue characterization with Gd-DTPA enhancement profiles.

  1990cited by this paper
• A comparison of the results of long‐term follow‐up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast

  1990cited by this paper
• MR imaging of the breast with Gd-DTPA: use and limitations.

  1989cited by this paper
• Breast cancer epidemiology.

  1988cited by this paper
• Patologia estructural y funcional

  1983cited by this paper
• Breast Carcinoma: Risk and Detection

  1981cited by this paper
• The epidemiology of cancer of the breast.

  1975cited by this paper
• Lobular carcinoma in situ. A long-term follow-up in 52 cases.

  1974cited by this paper
• Lobular carcinoma in situ of the breast.

  1973cited by this paper
• Changing incidence of breast cancer in Japanese-American women.

  1973cited by this paper
• Menopause and breast cancer risk.

  1972cited by this paper
• A genetic study of human breast cancer.

  1972cited by this paper
• Age at menarche and breast cancer.

  1971cited by this paper
• BENCE JONES PROTEINS AND LIGHT CHAINS OF IMMUNOGLOBULINS

  1969cited by this paper
• Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki.

  1968cited by this paper
• Cancer mortality among the Polish-born in the United States.

  1965cited by this paper
• LACTATION AND MENSTRUAL FUNCTION AS RELATED TO CANCER OF THE BREAST.

  1964cited by this paper
• A Genetical Study of Human Mammary Cancer

  1948cited by this paper
• A Further Report on Cancer of the Breast with Special Reference to its Associated Antecedent Conditions.

  year unknowncited by this paper

• No citing papers are available for this paper.